Biotech startups that raised a seed round in Asia
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Tushen Zhihe | Minhang | Seed | $1.4M | 2026-11-09 |
| M-Based | Ankara | Seed | $700K | 2026-10-01 |
| Viseur AI | Ankara | Seed | $350K | 2026-05-20 |
| Ivory | Bangalore | Seed | $1.0M | 2026-04-15 |
| Magicpen Bio | Hefei | Seed | $1.4M | 2026-02-06 |
| Micro-Ray Technology | Suzhou | Seed | $14.4M | 2026-01-23 |
| Nami Technology | Ho Chi Minh City | Seed | $4.0M | 2026-01-18 |
| Essentia Biosciences | Haidian | Seed | $14.3M | 2026-01-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 933 biotech startups in Asia whose last round is a seed round have raised $2.1B in total.
- 125 of them closed their most recent round in the last 12 months, $568.9M combined.
- The largest of those rounds is Active Technology's $69.4M angel round, dated November 2026.
- The most recent is Tushen Zhihe's $1.4M seed round on 9 November 2026.
- TIPS Program is an investor in 4 of them, more than any other fund.
- Health care is the most common other sector, with 675 companies (72%).
- 49% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (45% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 933| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang, China | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
| M-Based | M-Based develops eco-friendly alternative materials made from mycelium, the root structure of mushrooms. | Biotech | Ankara, Turkey | Seed | $700K | 2026-10-01 | $700K | Hatcher+, Sente Ventures, Fark Labs | 1 to 10 | |
| Viseur AI | Viseur AI provides a medical imaging platform that helps hospitals and labs deploy digital pathology and radiology workflows. | Artificial intelligence | Ankara, Turkey | Seed | $350K | 2026-05-20 | $897K | Turkey Development Fund | 11 to 50 | 2024 |
| Ivory | Ivory delivers neuroscience-based cognitive assessments that track brain health and detect early decline. | Biotech | Bangalore, India | Seed | $1.0M | 2026-04-15 | $2.5M | Capital A | 1 to 10 | 2022 |
| Magicpen Bio | Magicpen Bio produces and sells crop seeds and conducts agricultural research. | Biotech | Hefei, China | Seed | $1.4M | 2026-02-06 | $1.4M | Plum Ventures | 2023 | |
| Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Suzhou, China | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| Nami Technology | Nami Technology develops voice biometrics and natural language processing software. | Artificial intelligence | Ho Chi Minh City, Vietnam | Seed | $4.0M | 2026-01-18 | $6.0M | Thien Viet Securities | 51 to 100 | 2022 |
| Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Haidian, China | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
| Levinthal | Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. | Artificial intelligence | Hangzhou, China | Seed | $1K | 2025-12-09 | $1.6M | ZhenFund, Kaitai Capital, Pan-Lin Capital +1 | 1 to 10 | 2021 |
| Phrontline Biopharma | Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. | Biotech | Shanghai, China | Seed | $60.0M | 2025-11-21 | $73.8M | Decheng Capital, Med-Fine Capital | 11 to 50 | 2022 |
| Kybele's Garden | Kybele's Garden grows algae using bioponics and algae fermentation methods. | Biotech | Çankaya, Turkey | Seed | $420K | 2025-09-08 | $670K | Hatcher+, Sente Ventures | 1 to 10 | 2021 |
| Denovo Sciences | Denovo Sciences creates novel therapeutics using AI technologies. | Artificial intelligence | Yerevan, Armenia | Seed | $501K | 2025-05-05 | $626K | Triple S Ventures, European Network of AI Excellence Centres | 11 to 50 | 2019 |
| Mckenwei Technology | Mckenwei Technology provides synthetic biology manufacturing services for biochemical engineering. | Biotech | Changshan, China | Angel | $1.4M | 2024-11-12 | Changcai Private Equity Fund Company | 11 to 50 | 2023 | |
| AltiusHub | AltiusHub provides serialization, tracking, tracing, and warehousing software for pharmaceutical and defense industries. | Biotech | Hyderabad, India | Seed | $2.2M | 2024-09-18 | Y Combinator, Endiya Partners | 11 to 50 | 2023 | |
| Biofics | Biofics manufactures biogas plants and provides organic waste management services. | Biotech | Surat, India | Seed | $1.2M | 2024-08-28 | Upaya Social Ventures | 11 to 50 | 2016 | |
| Cellestetix | Cellestetix develops plant-based exosome formulas for skin, hair, and wellness regeneration. | Biotech | Istanbul, Turkey | Seed | $2.0M | 2024-08-16 | APY Ventures, Maxis, Arya Ventures +2 | 2020 | ||
| Cellivate Technology | Cellivate Technology provides proprietary platforms that help cellular meat companies accelerate cell growth. | Biotech | Singapore | Seed | $1.0M | 2024-08-06 | Antler, Venture Catalysts, Hatcher+ +2 | 1 to 10 | 2019 | |
| Shenji Changhua | Shenji Changhua is a biotechnology company focused on neurological diseases such as ALS. | Biotech | Changping, China | Seed | $13.8M | 2024-08-01 | $16.5M | Tsinghua Capital, MSA Capital, Zhongbo Juli | 11 to 50 | 2021 |
| Meiyou Technology | Meiyou Technology develops DNA synthesizers using enzymatic technology for long-fragment DNA synthesis and splicing. | Biotech | Shanghai, China | Angel | $1.4M | 2024-06-28 | MiraclePlus, Linear Capital, Danen Capital | 11 to 50 | 2023 | |
| Nanosafe Solutions | Nanosafe Solutions is a science startup that develops sustainable materials technology and products. | Biotech | Delhi, India | Seed | $375K | 2024-05-29 | IAN Group, IIML- Enterprise Incubation Centre | 11 to 50 | 2019 | |
| EFeed | EFeed sells nutritional animal feed directly to farmers for a range of species. | Artificial intelligence | Pune, India | Seed | $100K | 2024-05-14 | AngelList, AgFunder, Omnivore +1 | 11 to 50 | 2021 | |
| Taiyi Guanjia | Taiyi Guanjia operates a medical service platform that uses family doctors to connect technology with healthcare. | Biotech | Xuhui, China | Seed | $127.3M | 2024-05-08 | $127.3M | Mitsui Sumitomo Insurance Company | 251 to 500 | 2020 |
| Red Arrow Therapeutics | Red Arrow Therapeutics is a biotech firm developing systemic cytokine delivery and targeted intratumoral activation. | Biotech | Minato, Japan | Seed | $4.5M | 2024-04-23 | MassChallenge, UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures +2 | 11 to 50 | 2021 | |
| Mistikist | Mistikist delivers personalized AI-driven mental wellbeing sessions for stress relief and focus in minutes. | Biotech | Mugla, Turkey | Seed | $161K | 2024-04-01 | $161K | Startup Wise Guys, European Innovation Council, Microsoft Accelerator +2 | 1 to 10 | 2024 |
| EfA Technologies | EfA Technologies develops a programmable digital diagnostic lab-on-hand system. | Biotech | Caesarea, Israel | Seed | $6.5M | 2024-03-01 | eHealth Ventures | 1 to 10 | 2016 | |
| Algorithmic Biologics | Algorithmic Biologics builds software and technology that improves molecular testing processes. | Biotech | Bangalore, India | Seed | $2.5M | 2024-02-03 | $2.5M | Axilor Ventures, Bharat Innovation Fund | 11 to 50 | 2021 |
| Geneus Genetics | Geneus Genetics offers app-based DNA testing for health and talent genotyping. | Biotech | Phra Khanong, Thailand | Seed | $3.7M | 2024-01-30 | P.S.P. Ventures Co., Ltd. | 51 to 100 | 2019 | |
| Enzymecode Biotechnology | Enzymecode develops and produces brain health nutritional raw materials and food ingredients. | Biotech | Tianjin, China | Angel | $1.4M | 2023-12-29 | Draper Dragon | 11 to 50 | 2017 | |
| Ultimate Potential | Ultimate Potential is a brand offering hyper-personalized sports nutrition. | Biotech | Seoul, South Korea | Seed | $39K | 2023-12-26 | CNTTECH, Strong Ventures | 11 to 50 | 2020 | |
| Wisbiom | Wisbiom develops microecological preparations and microbiome-related products. | Biotech | Changping, China | Seed | $1.4M | 2023-12-18 | $1.4M | Hengxu Capital, ELIM Capital | 2017 |
Table 1. Biotech startups that raised a seed round in Asia: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 933.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Phrontline Biopharma | Phrontline Biopharma develops antibody-drug conjugate products to treat cancer. | Biotech | Shanghai, China | Seed | $60.0M | 2025-11-21 | $73.8M | Decheng Capital, Med-Fine Capital | 11 to 50 | 2022 |
| 2 | Micro-Ray Technology | Micro-Ray Technology supplies X-ray tubes and component solutions for medical imaging equipment such as CT machines. | Biotech | Suzhou, China | Seed | $14.4M | 2026-01-23 | $14.4M | Suzhou Xiangcheng Financial Holding Group | 11 to 50 | 2021 |
| 3 | Essentia Biosciences | Essentia Biosciences develops cell therapies, gene technology drugs, and medical devices. | Biotech | Haidian, China | Seed | $14.3M | 2026-01-01 | $14.3M | BioVenture, Haitang Fund, Beijing Molecular Technology | 1 to 10 | 2021 |
| 4 | Nami Technology | Nami Technology develops voice biometrics and natural language processing software. | Artificial intelligence | Ho Chi Minh City, Vietnam | Seed | $4.0M | 2026-01-18 | $6.0M | Thien Viet Securities | 51 to 100 | 2022 |
| 5 | Magicpen Bio | Magicpen Bio produces and sells crop seeds and conducts agricultural research. | Biotech | Hefei, China | Seed | $1.4M | 2026-02-06 | $1.4M | Plum Ventures | 2023 | |
| 6 | Tushen Zhihe | Tushen Zhihe provides artificial intelligence protein design services. | Artificial intelligence | Minhang, China | Seed | $1.4M | 2026-11-09 | $1.5M | Wuxi Capital, CHENGMEI VENTURES | 11 to 50 | 2023 |
| 7 | Ivory | Ivory delivers neuroscience-based cognitive assessments that track brain health and detect early decline. | Biotech | Bangalore, India | Seed | $1.0M | 2026-04-15 | $2.5M | Capital A | 1 to 10 | 2022 |
| 8 | M-Based | M-Based develops eco-friendly alternative materials made from mycelium, the root structure of mushrooms. | Biotech | Ankara, Turkey | Seed | $700K | 2026-10-01 | $700K | Hatcher+, Sente Ventures, Fark Labs | 1 to 10 | |
| 9 | Viseur AI | Viseur AI provides a medical imaging platform that helps hospitals and labs deploy digital pathology and radiology workflows. | Artificial intelligence | Ankara, Turkey | Seed | $350K | 2026-05-20 | $897K | Turkey Development Fund | 11 to 50 | 2024 |
| 10 | Levinthal | Levinthal uses artificial intelligence for protein design and co-evolution in food safety and medical care. | Artificial intelligence | Hangzhou, China | Seed | $1K | 2025-12-09 | $1.6M | ZhenFund, Kaitai Capital, Pan-Lin Capital +1 | 1 to 10 | 2021 |
Table 2. Biotech startups that raised a seed round in Asia: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | TIPS Program | Startup incubator | Gangneung, South Korea | 4 | 0% | ||
| 2 | Hatcher+ | Micro VC fund | Singapore | 3 | 0% | 1 | M-Based |
| 3 | Kaitai Capital | Venture capital firm | Hangzhou, China | 3 | 0% | 1 | Levinthal |
| 4 | Wuxi Capital | Angel group | Wuxi Shi, China | 2 | 0% | 1 | Tushen Zhihe |
| 5 | Sente Ventures | Corporate venture arm | Chicago, United States | 2 | 0% | 1 | M-Based |
| 6 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 0% | 1 | Zhonghe Gene |
| 7 | Haitang Fund | Venture capital firm | Nankai, China | 2 | 0% | 2 | Zhonghe Gene, Essentia Biosciences |
| 8 | Pan-Lin Capital | Venture capital firm | Shanghai, China | 2 | 0% | 1 | Levinthal |
| 9 | IAN Group | Angel group | New Delhi, India | 2 | 0% | ||
| 10 | Puhua Capital | Venture capital firm | Hangzhou, China | 2 | 0% | ||
| 11 | Y Combinator | Startup accelerator | Mountain View, United States | 2 | 0% | ||
| 12 | MiraclePlus | Startup accelerator | Haidian, China | 2 | 0% | ||
| 13 | Linear Capital | Venture capital firm | Shanghai, China | 2 | 0% | ||
| 14 | AgFunder | Micro VC fund | San Francisco, United States | 2 | 0% | ||
| 15 | UTEC - The University of Tokyo Edge Capital Partners | Venture capital firm | Tokyo, Japan | 2 | 0% |
Table 3. Biotech startups that raised a seed round in Asia: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 675 | 72% | $2.0B |
| Software | 119 | 13% | $201.4M |
| Artificial intelligence | 86 | 9% | $195.3M |
| Hardware | 35 | 4% | $38.8M |
| Energy | 11 | 1% | $7.4M |
| Commerce | 10 | 1% | $3.0M |
| Education | 7 | 1% | $3.0M |
| Fintech | 6 | 1% | |
| Cybersecurity | 4 | 0% |
Table 4. Biotech startups that raised a seed round in Asia by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 933 | 100% | $1.4M |
Table 5. Biotech startups that raised a seed round in Asia by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
Table 6. Biotech startups that raised a seed round in Asia by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech startups that raised a seed round in Asia by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 4 | 3% | $71.5M |
| October 2026 | 10 | 8% | $67.4M |
| September 2026 | 11 | 9% | $34.8M |
| August 2026 | 10 | 8% | $74.3M |
| July 2026 | 12 | 10% | $12.2M |
| June 2026 | 12 | 10% | $14.1M |
| May 2026 | 10 | 8% | $18.4M |
| April 2026 | 7 | 6% | $2.1M |
| March 2026 | 13 | 10% | $116.6M |
| February 2026 | 7 | 6% | $42.9M |
| January 2026 | 11 | 9% | $35.5M |
| December 2025 | 16 | 13% | $19.2M |
| November 2025 | 2 | 2% | $60.0M |
Table 8. Biotech startups that raised a seed round in Asia: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 107 | 11% | $489.8M |
| 2025 | 115 | 12% | $313.0M |
| 2024 | 130 | 14% | $274.8M |
| 2023 | 125 | 13% | $211.8M |
| 2022 | 98 | 11% | $320.7M |
| 2021 | 88 | 9% | $232.6M |
Table 9. Biotech startups that raised a seed round in Asia by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 140 | 15% |
| 2020 to 2022 | 300 | 33% |
| 2015 to 2019 | 322 | 36% |
| 2010 to 2014 | 93 | 10% |
| Before 2010 | 50 | 6% |
Table 10. Biotech startups that raised a seed round in Asia by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 263 | 38% |
| 11 to 50 | 316 | 45% |
| 51 to 100 | 75 | 11% |
| 101 to 250 | 29 | 4% |
| 251 to 500 | 8 | 1% |
| 501 to 1,000 | 4 | 1% |
| 1,001 to 5,000 | 3 | 0% |
| 5,001 to 10,000 | 1 | 0% |
Table 11. Biotech startups that raised a seed round in Asia by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in Asia. On 16 November 2026 that is 933 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 933 rows: 471 have no round amount, 0 no city and 505 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Asia whose last round is a seed round are on the list?
- 933, in the file dated 16 November 2026. 125 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 933 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.